Randomized Study for Patients With Follicular Lymphoma Needing Treatment
2 parallel studies.
- For young patients (18-60 years): randomization between CHVP + interferon for 18 months
and 4 CHOP followed by autotransplant after TBI
- For elderly patients (>60 years): randomization between CHVP + interferon for 18 months
and fludarabine 5 days every months for 6 months
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Progression-free survival
Bertrand Coiffier, MD
Study Chair
Hospices Civils de Lyon
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Gelf-94
NCT00140569
January 1994
January 2004
Name | Location |
---|